These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23237707)

  • 21. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
    Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
    Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.
    Mao Y; Wang J; Zhang M; Fan W; Tang Q; Xiong S; Tang X; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xu L; Yin R; Zhu J
    Oncotarget; 2017 Feb; 8(7):10954-10965. PubMed ID: 28009988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
    Yamaguchi M; Takata K; Yoshino T; Ishizuka N; Oguchi M; Kobayashi Y; Isobe Y; Ishizawa K; Kubota N; Itoh K; Usui N; Miyazaki K; Wasada I; Nakamura S; Matsuno Y; Oshimi K; Kinoshita T; Tsukasaki K; Tobinai K
    Cancer Sci; 2014 Nov; 105(11):1435-41. PubMed ID: 25181936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
    Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.
    Gualco G; Domeny-Duarte P; Chioato L; Barber G; Natkunam Y; Bacchi CE
    Am J Surg Pathol; 2011 Aug; 35(8):1195-203. PubMed ID: 21716086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.
    Pongpruttipan T; Kummalue T; Bedavanija A; Khuhapinant A; Ohshima K; Arakawa F; Niino D; Sukpanichnant S
    Diagn Pathol; 2011 Aug; 6():79. PubMed ID: 21867533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary spleen extranodal NK/T cell lymphoma, nasal type, with bone marrow involvement and CD30 positive expression: a case report and literature review.
    Cao Q; Huang Y; Ye Z; Liu N; Li S; Peng T
    Diagn Pathol; 2014 Sep; 9():169. PubMed ID: 25183396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous NK/T-cell lymphoma of nasal type: an age-related lymphoproliferative disease?
    Wu CC; Takahashi E; Asano N; Miyata-Takata T; Takata K; Furukawa K; Elsayed AA; Hu LM; Satou A; Kohno K; Kosugi H; Ohashi K; Kinoshita T; Nakamura S; Kato S
    Hum Pathol; 2017 Oct; 68():61-68. PubMed ID: 28873353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma.
    Lee JY; Kim JH; Bang H; Cho J; Ko YH; Kim SJ; Kim WS
    Sci Rep; 2021 May; 11(1):10342. PubMed ID: 33990633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
    Guasparri I; Bubman D; Cesarman E
    Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.
    Minamitani T; Ma Y; Zhou H; Kida H; Tsai CY; Obana M; Okuzaki D; Fujio Y; Kumanogoh A; Zhao B; Kikutani H; Kieff E; Gewurz BE; Yasui T
    Proc Natl Acad Sci U S A; 2017 May; 114(18):4751-4756. PubMed ID: 28351978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laryngeal Extranodal Nasal-type Natural Killer/T-cell Lymphoma: A Clinicopathologic Study of 31 Cases in China.
    Xiang CX; Chen ZH; Zhao S; Gao LM; Tao Q; Zuo Z; Liu XY; Liu WP
    Am J Surg Pathol; 2019 Jul; 43(7):995-1004. PubMed ID: 31045893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type, is associated with disease progression and prognosis.
    Liu J; Liang L; Huang S; Nong L; Li D; Zhang B; Li T
    Hum Pathol; 2019 Jan; 83():166-176. PubMed ID: 30218753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.
    Jiang QP; Liu SY; Yang YX; Tan XX; Peng J; Xiong ZT; Li Z
    Diagn Pathol; 2012 Oct; 7():133. PubMed ID: 23031227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary extranodal NK/T cell lymphoma, nasal-type of uterus with adenomyosis: a case report.
    Fang JC; Zhou J; Li Z; Xia ZX
    Diagn Pathol; 2014 May; 9():95. PubMed ID: 24886075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
    Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
    Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.